|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 December 2017 |
|
Main ID: |
NCT03212846 |
|
Date of registration:
|
07/07/2017 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Muscle Spasticity Reduction in Children With Cerebral Palsy by Means of Hippotherapy
|
|
Scientific title:
|
Muscle Spasticity Reduction in Children With Cerebral Palsy by Means of Hippotherapy: a Randomized Controlled Trial |
|
Date of first enrolment:
|
June 2016 |
|
Target sample size:
|
50 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT03212846 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Spain
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Primor diagnosis of spastic cerebral palsy
- Children aged 3-14
Exclusion Criteria:
- Children with recent injection of botulinium toxin, surgery, or any planned medical or
surgical interventions.
Age minimum:
3 Years
Age maximum:
14 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Neuromuscular Diseases in Children
|
|
Cerebral Palsy, Spastic
|
|
Spasticity, Muscle
|
|
Intervention(s)
|
|
Other: Hippotherapy
|
|
Primary Outcome(s)
|
|
Modified Ashworth Scale (MAS)
[Time Frame: 12 weeks]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|